Hugh Regan
Analyst · Colliers
Thank you. A good part of EMS' growth in the second quarter has been in support of power management devices for the mobile handset market and the home computing space where many people are working or studying from home during the COVID-19 pandemic. We are seeing that companies, in general, are realizing they can remain in production mode in a COVID restricted world, specifically for inTEST, our customers have a higher level of confidence than they did at the onset of the pandemic and the respective abilities to plan and execute, and therefore their need for more equipment from us as the pandemic unfolds. Q2 consolidated bookings of $13.9 million were consistent with the $13.8 million reported in the first quarter, and order flow has strengthened, especially in the analog mixed-signal production test sector, which you’ll see reflected in our guidance for the third quarter. For the second quarter, Semi bookings increased 9% sequentially to $7.3 million, while Multi Market bookings for the same period decreased 7% to $6.6 million. On a long-term basis, a diverse set of end applications is driving our business growth, confirming our Multi Market strategy. On a quarterly basis, the sequential decline in Multi Market bookings was largely due to the fact that we had a very strong orders that came in at the end of the first quarter, which makes the comparison difficult, if not less meaningful. While most of our manipulator customers have been essential and have remained open, there are a number who are not, places like fabricators, integrators, weld shops and auto manufacturers who were closed down during the quarter by mandate, and were not able to open for business or are still well below normal business levels. Q2 consolidated revenues of $13.3 million increased 18% sequentially and were 2% above our guidance and 10% above consensus, largely fueled by the semi market, which, as I just noted, has increasingly shown strength. Breaking down overall revenues, Semi revenues for the second quarter increased 37% sequentially to $6.9 million, and Q2 Multi Market revenues increased by 3% to $6.4 million. Multi Market revenues were predominantly driven by industrial and defense/aerospace markets. As we have noted in the past, our ultimate goal is to grow Multi Market business to reduce the impact of the volatility that is inherent in the Semi market. Let’s now turn to our two operating segments, beginning with Thermal, which consists of Ambrell and iTS. Thermal is responsible for all Multi Market revenue as well as important revenue from semiconductor front-end manufacturing and back-end test. Despite the continued impacts of COVID-19, business activity was good, and we entered Q3 with a stronger backlog, with several key projects and ongoing orders that we expect will close in the third quarter. Q2 Thermal bookings of $10.4 million were relatively consistent with the $10.5 million reported in Q1. And Thermal net revenues for the quarter of $9.5 million were up 2% compared with the $9.3 million reported in Q1. The pandemic has limited our ability to provide service to certain of our customers, which typically has contributed approximately 8% to 10% of consolidated revenues. This is due to travel restrictions imposed during the quarter along with customers prohibiting on-site visits. The net result of this is reduced service revenue, which, in turn, has negatively impacted our gross margin. Compared to the year ago period, consolidated service revenues are down 29%. Semiconductors remain an important driver of our Thermal business, driven by continued import orders in wafer deposition and silicon carbide crystal growth. Key thermal market applications also include defense/aerospace and industrial, which includes packaging, automotive and medical. These applications as well as Semi continue to account for the majority of business. We continue to focus on advanced applications within our Thermal segment, which are key to our long-term growth drivers and advance our technical capabilities as well as diversification. Now let’s turn to the EMS products segment, which predominantly serves production test for analog and mixed-signal semiconductor applications. The semiconductor market has been much stronger recently with our EMS business clear – which our EMS business clearly reflects. Q2 EMS bookings increased 6% sequentially to $3.5 million, and EMS revenues of $3.8 million were up 100% sequentially. Our business model is one of our most significant strengths and is based on identifying strategic opportunities in a wide array of markets and industries and leveraging our technology and product suite to partner with our customers. We provide them with the best technology for their application and to advance their technology road maps, all towards building a strong preferred vendor relationship. One of the more noteworthy things we are seeing is the growth of our Thermonics chiller brand within our Thermal segment. This business continues to gain momentum and is becoming exciting driver of future growth. Organic growth of this nature requires commitment and perseverance, but we are excited by its potential. We’ve talked quite a bit about the cannabis business related to chillers, but we believe the most important aspect is the broad demand that chillers, like induction heating tools, command. They can be sold into a cross-section of customers, OEMs, end users and integrators. And in addition to the cannabis market, we have a myriad of customers we are actively engaged with, representing markets such as defense/aerospace, as I noted earlier, as well as semi and the broader industrial market. As usual, we’re precluded from giving specific details regarding customers, but we will keep you updated on our progress in this area. As we noted last year, relative to M&A, uncertain economic conditions, along with scarce resources due to COVID-19 have, by necessity, taken precedence over our long-term growth strategy, and we have not seen a change. While our M&A strategy – or excuse me, while our M&A activity, of course, is an important component of our growth strategy, there has been no activity in the second quarter. I’ll now turn to my detailed financial review. I provided details of bookings and net revenues earlier in the call. Our second quarter gross margin of 46% came in at the high end of our guidance range and was up from the 43% gross margin we reported for the first quarter, reflecting a more favorable absorption of fixed production costs at higher revenue levels, which was partially offset by increased component material costs, which grew from 30.3% in Q1 to 33.0% in Q2. Fixed manufacturing costs decreased 3% or $82,000 during the quarter due to reductions in operations staff. Selling expense decreased by 14% sequentially to $1.8 million for the second quarter, driven primarily by reduced levels of travel as well as lower salary and benefit costs and, to a lesser extent, reduced spending on advertising and lower commission expense. Engineering and product development expense decreased 6% sequentially to $1.2 million, primarily as a result of decreased use of third-party product development consultants as well as reduced patent legal costs. General and administrative expense was $2.9 million for both the first and second quarters, with reduced salary and benefit expense fully offset by increased professional fees and profit-related bonus accruals. We accrued income tax expense of $13,000 in the second quarter, reflecting a 7% effective tax rate. This compares to a $250,000 income tax benefit booked in the first quarter, which reflected an effective tax rate of 18%. We expect that our effective tax rate will range from 15% to 17% through the balance of 2020. The lower effective tax rate in the second quarter was driven by additional book to tax return adjustments. For the second quarter, we reported earnings of $170,000 or $0.02 per diluted share compared to a net loss of $1.1 million or $0.11 per diluted share for the first quarter. Our second quarter earnings exceeded our EPS guidance by $0.02 and the consensus EPS estimates by $0.08 per share. Diluted average shares outstanding were $10.3 million for the second quarter. During the second quarter, we issued 15,840 shares of restricted stock and did not repurchase any shares. EBITDA was $672,000 for the second quarter compared to a negative $927,000 for the first quarter. Consolidated headcount at June 30 was 197, a reduction of 8 or 4% from the level we had at March 31. I’ll now turn to our balance sheet. Cash and cash equivalents grew by $106,000 sequentially to $7.4 million and cash flow provided by operations was $200,000 for the second quarter. We currently expect cash and cash equivalents to increase by year-end, and as of today, cash stands at $6.5 million. Accounts receivable increased by $1.4 million during the second quarter and was $9.5 million at June 30, with 65 DSOs, no change from where we were at March. Inventories increased $210,000 or 3% sequentially. Our backlog at the end of June was $8.7 million, up from $8.1 million at March 31. As to guidance, as noted in our earnings release, for the third quarter, we are guiding up for both revenue and EPS. We expect that our net revenues for the quarter ending September 30, 2020, will be in the range of $13.5 million to $14.5 million and that our GAAP financial results will range from net earnings of $0.01 to $0.06 per diluted share. On a non-GAAP basis, our adjusted net earnings per diluted share will range from $0.04 to $0.09 per diluted share, and we currently expect our third quarter gross margin will range from 46% to 48%. Our guidance is predicated on business trends we are currently seeing as well as our expectations for the balance of the quarter. We are encouraged by the overall improvement in our orders and the tone from our customers. And as I noted earlier, I believe companies in general are realizing they can remain in production mode in a COVID-restricted world. But there is still uncertainty related to the pandemic resurgence and we are being cautiously optimistic until we have a better sense of how it will all play out. While there is still considerable end market uncertainty, further compounded by the pandemic and the geopolitical uncertainty related to China, the diversification of our customer base remains the anchor of our business, and we believe our long-term fundamentals remains firmly intact. Finally, I would once again like to thank Jim Pelrin for his 19 years of dedicated service to inTEST Corporation and wish him well. And we look forward to welcoming our new incoming CEO, Nick Grant, when he joins us later this month. Until then, I’m happy to keep the CFO or CEO chair warm. Operator, that concludes our formal remarks. We can now take questions.